Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
2015 1
2016 2
2018 1
2019 3
2020 1
2021 3
2022 5
2023 5

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Canadian perspectives: update on inhibition of ALK-positive tumours in advanced non-small-cell lung cancer.
Melosky B, Cheema P, Agulnik J, Albadine R, Bebb DG, Blais N, Burkes R, Butts C, Card PB, Chan AMY, Hirsh V, Ionescu DN, Juergens R, Morzycki W, Poonja Z, Sangha R, Tehfe M, Tsao MS, Vincent M, Xu Z, Liu G. Melosky B, et al. Curr Oncol. 2018 Oct;25(5):317-328. doi: 10.3747/co.25.4379. Epub 2018 Oct 31. Curr Oncol. 2018. PMID: 30464681 Free PMC article. Review.
The dawn of a new era, adjuvant EGFR inhibition in resected non-small cell lung cancer.
Melosky B, Cheema P, Juergens RA, Leighl NB, Liu G, Wheatley-Price P, Sacher A, Snow S, Tsao MS, McLeod D, Chu Q. Melosky B, et al. Ther Adv Med Oncol. 2021 Nov 15;13:17588359211056306. doi: 10.1177/17588359211056306. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 34804219 Free PMC article. Review.
BACKGROUND: Adjuvant platinum-based chemotherapy is standard of care for patients with resected stage IIA/B or IIIA NSCLC. Overall survival is suboptimal due to the high metastatic potential of early-stage NSCLC and there is substantial clinical need for additional efficac …
BACKGROUND: Adjuvant platinum-based chemotherapy is standard of care for patients with resected stage IIA/B or IIIA NSCLC. Overall su …
Lymphoproliferative disorders after renal transplantation in patients receiving triple or quadruple immunosuppression.
Melosky B, Karim M, Chui A, McBride M, Cameron EC, Yeung CK, Landsberg D, Shackleton C, Keown PA. Melosky B, et al. J Am Soc Nephrol. 1992 Jun;2(12 Suppl):S290-4. doi: 10.1681/ASN.V212s290. J Am Soc Nephrol. 1992. PMID: 1323341 Review.
Cases of neoplasm were identified by linking the computerized databases of the British Columbia (B.C.) Transplant Society and the B.C. Cancer Agency. B.C. Cancer Statistics for 1988 were used to determine relative risk. ...
Cases of neoplasm were identified by linking the computerized databases of the British Columbia (B.C.) Transplant Society and the …
Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLC.
Cheema PK, Banerji SO, Blais N, Chu QS, Juergens RA, Leighl NB, Sacher A, Sheffield BS, Snow S, Vincent M, Wheatley-Price PF, Yip S, Melosky BL. Cheema PK, et al. Curr Oncol. 2023 Jul 6;30(7):6473-6496. doi: 10.3390/curroncol30070476. Curr Oncol. 2023. PMID: 37504336 Free PMC article.
Canadian Consensus Recommendations on the Management of MET-Altered NSCLC.
Cheema PK, Banerji SO, Blais N, Chu QS, Desmeules P, Juergens RA, Leighl NB, Sheffield BS, Wheatley-Price PF, Melosky BL. Cheema PK, et al. Curr Oncol. 2021 Nov 9;28(6):4552-4576. doi: 10.3390/curroncol28060386. Curr Oncol. 2021. PMID: 34898564 Free PMC article.
21 results